Emphysema is a progressive lung disease characterised by loss of lung parenchyma with associated functional changes including decreased tissue elastance. Here we report β1 integrin is a novel target for tissue repair and regeneration in emphysema. We show a single dose of a monoclonal antibody against β1 integrin induced both functional and structural reversal of elastase-induced lung injury in vivo, and we found that similar matrix remodelling changes occurred in human lung tissue. We also identified a potential mechanism of action as this allosteric modulation of β1 integrin inhibited elastase-induced caspase activation, F-actin aggregate formation and changes in cellular ATP levels. This was accompanied by maintenance of β1 integrin levels and inhibition of caveolin-1 phosphorylation. We propose that allosteric modulation of β1 integrin-mediated mechanosensing prevents cell death associated with lung injury and progressive emphysema, thus allowing cells to survive and for repair and regeneration to ensue.
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is characterised by poorly reversible and progressive airflow limitation associated with chronic bronchitis and emphysema (1) . There are currently no effective treatments for emphysema to halt, slow or reverse the disease (1) . Prospective treatments are focussed on the amelioration of the inflammation associated with the disease. The emphasis of our studies has been on the largely unexplored areas of repair and regeneration in emphysema.
Recent paradigms proposed in emphysema pathogenesis include the interaction of apoptosis, oxidative stress and protease/antiprotease imbalance where inflammation is a consequence to cumulative cellular injury (2) . The cell responses to such injuries are directed toward cell arrest, or, if the damage is beyond repair, toward cell death (3) .
This leads to the hypothesis that alveolar cell apoptosis is a critical determinant in the pathogenesis and progression of emphysema; a key observation documented both in human and animal models (4;5) . Apoptosis may be induced by physical insult, ligation of receptors, or altered extracellular matrix (ECM) composition and/or attachment.
The ECM interacts with integrins and modifies their function. Integrins are a family of heterodimeric cell surface receptors composed of α and β subunits. There is substantial molecular evidence for the role of integrins in tissue organisation due to their role in cell-ECM and cell-cell adhesion (6;7) . These properties give integrins key roles in cell growth, differentiation, migration, and survival. Little is known about the role of β1 integrin specifically in the lung in health and disease, but interestingly, β1 integrin has been implicated in cardiac fibrosis (8) and epithelial proliferation (9). 4 We questioned whether, in emphysematous lung injury, β1 integrin function is involved in regulation of apoptosis of lung cells, with the corollary that modifiers of integrin function could be therapeutically beneficial. We have established an in vitro model system which replicated features of elastase-induced injury in vivo. Using this system, we identified a novel mechanism of β1 integrin-mediated repair in which allosteric modulation of the receptor inhibited caspase activation, F-actin aggregate formation and fluctuations in cellular ATP levels. This inhibition was obtained under conditions in which the total β1 expression was unchanged and clustering inhibited.
Results
We used several functional monoclonal antibodies, one of which, predicted to modify β1 integrin allostery by binding to the hybrid domain of the receptor, had a marked therapeutic effect. This antibody, JB1a, binds to an epitope within the β1 integrin's hybrid domain irrespective of conformational state of the receptor. Targeting amino acid sequences in this region using antibodies have been reported to stabilise the physiological intermediate state of the receptor in a similar fashion as an allosteric antagonist (10).
Allosteric modulation of β1 integrin increases ECM production
We first investigated whether β1 integrin allosteric modulation altered the ECM, focussing on perlecan because of its known role in basement membrane integrity. In a co-culture of primary human alveolar epithelial cells with lung interstitial cells, the anti-β1 integrin antibody JB1a caused an increase in perlecan (figure 1a); a change that 5 persisted for 24 hours and was partially sensitive to pre-treatment with cycloheximide and the non-specific MMPs activator aminophenylmercuric acetate (APMA). Treatment with neutralising anti-MMPs 7 and 9 antibodies failed to produce a similar increase in perlecan expression. The changes in perlecan in response to JB1a were accompanied by an increase in tissue inhibitors of metalloproteinase-1 (TIMP1) initially (figure 1b) and pro-MMP-9 subsequently (figure 1c). The results indicate that JB1a-induced changes in proteoglycan are not solely due to alteration in the MMP/TIMP balance. Similar responses in human lung explants and the alveolar cell line, NCI-H441, were also obtained and were specific to JB1a treatment (data not shown). As controls we demonstrated that the anti-β1 integrin antibody TS2/16, which binds the 207-218 amino acid sequence, and 6S6 clone, which binds a discontinuous unmapped epitope, had no effect on proteoglycans.
Allosteric modulation of β1 integrin effects reversal of emphysematous injury in vivo.
In order to investigate whether allosteric modulation of β1 integrin was of therapeutic value, mice were treated with the anti β1 integrin monoclonal antibody, JB1a, or vehicle, either once on day 14 (21 day group, 21d) or on days 21 and 28 (35 day group, 35d) after elastase instillation and the achievement of maximal air space enlargement on the basis of a pilot time course study and previous reports (11). Both JB1a and 6S6 clones bind β1 integrin in mouse tissues (12). We have further confirmed that JB1a binds β1 integrin in murine tissue by immunoprecipitation followed by mass spectrometry and western analyses to ascertain the identity of the protein to which the JB1a clone binds in murine tissues (data not shown). An additional group receiving 6 elastase and the isotype control IgG1, MOPC21, was performed and showed no reversal of elastase-induced structural damage (data not shown). The clone 6S6 did not induce repair in vivo (data not shown). This clone is known to induce aggregation in addition to adhesion blocking.
Allosteric modulation of β1 integrin effects functional reversal of emphysematous injury in vivo.
As expected, there was a marked leftward shift in the respiratory pressure-volume curve (PV) in response to elastase, and there was a progressive increase in the PV shape exponential constant, k, particularly in the 35 day group (figure 2a-b). This shift was reversed by JB1a treatment (figure 2a-b, for 35 day data, 21 day data not shown).
Furthermore, the effect of elastase treatment on the peak pressures and quasi-static elastance derived from the PV curves were significantly reversed by JB1a treatment (figures 2c and 2d).
Allosteric modulation of β1 integrin effects structural reversal of emphysematous injury in vivo.
Lung morphometry demonstrated that JB1a treatment also reversed elastase-induced air space enlargement (figures 3a and 3b). The explanation for the discrepancy between the functional and structural differences of the 21day and 35day treatment groups may reflect the presence of inflammation, noted histologically in the 21day but not 35 day group. The functional reversal was accompanied by reversal in elastase-induced damage to elastic fibres (data not shown). 7 To ascertain the effects of allosteric modulation of β1 integrin on lung structural repair, we assessed the number of contiguous airspaces using image analysis of histological sections from the 21day group (Figure 3c -e, Figure 4 for method). Elastase pre-treatment decreased the number of contiguous airspaces and was reversible by JB1a treatment (Figure 3c ). In addition, elastase pre-treatment caused a decrease in the number of septal junctions which was partially reversed by JB1a (Figure 3d ). No change was seen in the number of septal ends (Figure 3e ).
The effect of allosteric modulation of β1 integrin on alveolar septation
Using 3D image reconstructions of expression pattern of TTF-1 and GATA-6 in 21day group animals, two transcription factors which control septation in the developing lung (13;14) were investigated.
GATA-6 expression demarcates alveolar boundaries, and is increased following elastase-induced injury
Following elastase-induced air space enlargement in the lung in the 21day group, an increase in GATA-6 staining was observed in alveoli in comparison to vehicle-treated animals ( Figure 5 ). JB1a treated animals exhibited a less pronounced GATA-6 staining in comparison to elastase-treated mice ( Figure 5 ). However, the pattern of GATA-6 expression displayed marked differences following antibody treatment in comparison to vehicle-treated mice, as revealed by 3D reconstructions of immunohistochemicallylabelled slides. Airspace enlargement was patchy in 21day JB1a-treated lungs (Figure 5) and these were rich in GATA-6 expressing structures, many of which were elongated relative to vehicle-treated controls whereas the non-emphysematous areas displayed punctate GATA-6 structures as in vehicle-treated lungs ( Figure 5 By assessing the co-distribution of GATA-6 and TTF-1 in 3D reconstructions, it was determined that areas of TTF-1 cell hyperplasia ( Figure 5 ) did not co-localise with GATA-6 expression but rather appeared adjacent. Thus, it would appear that in the lung, GATA-6 and TTF-1 have discrete expression domains.
Allosteric modulation of β1 integrin reduced cell death after emphysematous injury in vivo. The cellular mechanism of reversal of emphysema using an in vitro system induced by β1 integrin allosteric modulation.
Elastase can induce apoptosis of epithelial cells secondary to altered attachment (anoikis), accompanied by alteration in mitochondrial permeability and caspase activation (18). In a co-culture of adult human lung fibroblasts over-layered with NCI-H441 cells, under cyclic mechanical stimulation, we show that elastase treatment caused a significant increase in caspase 3 and 7 activity, consistent with previous reports (19).
Addition of JB1a to the cultures inhibited elastase-induced caspase activation in a similar fashion to the broad spectrum caspase inhibitor, ZVAD-fmk (figure 7a).
Furthermore, we found that elastase treatment increased F-actin aggregates, changes inhibited by both JB1a and ZVAD-fmk (figure 7b). In time lapse studies and 3D reconstructions, we were able to demonstrate the increase in de novo F-actin formation during the course of elastase-induced injury which was followed by activation of caspase 3 and 7 ( Figure 7c , for movies see supplementary online data).
Formation of F-actin from monomeric G-actin is energy dependent and under ATP depletion conditions, there is a net conversion of monomeric G-actin to polymeric F-actin. We measured ATP levels in co-cultures in response to elastase and JB1a. Elastase reduced the levels of ATP, a response inhibited by JB1a ( figure 8 ). Of note is also the amplitude of fluctuations in ATP level in response to elastase, a pattern attenuated by JB1a.
β1 integrin-mediated adhesion has been shown to regulate cholesterol-rich membrane microdomain internalisation mediated by phospho-caveolin- 1 (20) . In cocultures, elastase significantly reduced cell membrane-associated β1 integrin levels (figure 9a) and induced phosphorylation of caveolin-1 within two hours; changes inhibited by JB1a (figure 9b-c).
Discussion
In this report we have investigated the role of β1 integrin in lung repair in emphysema. We questioned whether β1 integrin becomes allosterically activated in epithelial or mesenchymal cells, with the corollary that allosteric antagonists could be therapeutically beneficial. The key finding of our investigation was that by direct allosteric modulation of β1 integrin with a single dose of monoclonal antibody, both functional and structural reversal of elastase-induced tissue injury were induced in vivo.
This effect appeared to be due to increase septation. We further demonstrate a potential cellular mechanism for this β1 integrin-mediated repair. In order to do so, we established an in vitro model system which replicated features of elastase-induced emphysema in vivo. We identified that allosteric modulation of β1 integrin inhibited caspase activation, F-actin aggregate formation and fluctuations in cellular ATP levels, under conditions in which the total β1 expression was changed and clustering inhibited. It is important to note that although the knock-out or transgenic approaches have highlighted the crucial role for β1 integrin, they do not elucidate more subtle functions, The expression of activation epitopes of β1 integrin, and hence a fully extended active conformation, is present in asthmatic patients and correlates with airway hyperresponsiveness (27). Full activation of β1 integrin is required for MMP activation (7), an important component during remodelling. However, a function modifying antibody which induces an allosteric modulation locking the receptor in an intermediary low affinity physiological state increased proliferation in human mammary epithelial cells (28).
We also questioned how allosteric modulation promoted structural repair in emphysematous lungs. The two main events in lung morphogenesis are branching of the conducting airways and alveolar septation. In emphysema, the complexity of individual alveoli is lost. Additionally, it is known that the formation of new septa slows with advancing age, and it is feasible that emphysema in the adult may reflect a defect in septation. Alveolar septation is regulated by transcription factors such as GATA-6 and TTF-1 (29;30). Septation involves the subdivision of the large, primitive airspace via the budding of type II progenitor cells from the primary septa into the alveolar space.
These new secondary septa may meet with one another before differentiating into the thin, squamous type I epithelial cells typical of mature septa (31;32). By virtue of their importance during alveolarisation in the postnatal lung, it is possible that the expression levels of GATA-6 and TTF-1 may highlight restrictions on new septa formation in adult lung. To address this issue, we employed image processing techniques including 3D reconstructions of TTF-1 and GATA-6 expression patterns and automated stereological counting methods as a means of assessing whether there is a relationship between the expression of these transcription factors and the incidence of septation in after elastseinduced injury. We demonstrated that GATA-6 expression is increased following elastase-injury and associates with a decrease in the number of alveolar septal junctions and contiguous airspaces. In addition, allosteric modulation of β1 integrin induced a marked hyperplasia of TTF-1 expressing cells, and attenuated the GATA-6 upregulation associated with elastase-injury. GATA-6 regulates differentiation of the alveolar type II cell, and may distinguish an intermediate cell type with characteristics of both the type II and type I cell (33). Our observation that GATA-6 is highly expressed in the thickened septa that surround enlarged airspaces in antibody-treated lungs is consistent with this possibility, and may reflect epithelial cells in the process of differentiating from type II to type I cells. However, it is additionally possible that the existence of these thick, cable-like cells highlights a possible failure of septal cells to differentiate into thin, type I cells in emphysematous areas. It has been recently suggested that newly transdifferentiated cells in the lung are more prone to cell death and may be a mechanism for limiting physiologic repair after injury (34). Notwithstanding this, it is noteworthy that in all instances GATA-6 was expressed in only a portion of alveolar epithelial cells, and that these were not connected with one another.
Analysis of TTF-1 in vehicle-treated lungs revealed that TTF-1 was expressed in alveolar corner cells and cells of the free septal ends. The former are most likely type II epithelial cells whereas the latter may reflect type II cells in the process of transdifferentiating into myofibroblasts (34-36). Epithelial-mesenchymal transitions are a feature of the alveolus and it is feasible that the type II cell may migrate to a free septal end whereby it differentiates into a myofibroblast. The myofibroblast, committed to ECM deposition and tissue repair, may present as a considerable boon to a remodelling alveolus. 3D reconstructions revealed that TTF-1 expression patterns in elastase-injured lungs were similar to those of vehicle-treated lungs. By contrast, the number of TTF-1 expressing cells increased following antibody treatment and 3D reconstructions revealed a marked hyperplasia of TTF-1 expressing cells in both emphysematous and repaired regions. These findings suggest that modulating β1 integrin function allows septation to proceed in damaged lungs by altering the pool of GATA-6 and TTF-1 expressing cells.
On the basis of these findings and the in vivo TUNEL data, we investigated the cellular mechanism of epithelial-mesenchymal response to emphysematous injury in vitro. Butler and colleagues reported that ligand or antibody-induced activation and/or clustering of integrins promotes actin polymerisation in a dose-dependent manner (19).
Changes in cytomechanics is a determinant of cell fate (21;37). Evidence that F-actin aggregates are involved in cellular injury leading to death comes from studies where cisplatin-induced loss of cell-cell contacts was associated with the increased formation of F-actin stress fibres and subsequently apoptosis (38). Changes in actin dynamics also affect mitochondrial function and release of reactive oxygen species eliciting death signals (reviewed in detail in (39)). Retro-retinoids (a metabolite of retinol) trigger apoptosis mediated by F-actin aggregate formation (40). Indeed, several serine proteases including elastase have been shown to decrease mitochondrial membrane potential, release of cytochrome c to the cytosol, and cleavage of caspases-9 and -3 in both lung fibroblasts and bronchial epithelial cells (18;41;42). Lipopolysaccharide has been reported to increase integrin function and cell-matrix adhesion, leading to impaired enterocyte migration in necrotizing enterocolitis (18;43).
We have found that in our in vitro epithelial mesenchymal cultures, elastase induced caspase activation. The effect was accompanied by an increase in F-actin. The live cell imaging provides a stronger evidence of de novo increase in the formation of actin aggregates since the phalloidin staining fails to demonstrate the newly formed aggregate. We used an experimental strategy in which cells were loaded with labelled monomeric actin just prior to the onset of injury. Furthermore, we were able to show caspase activation in real-time. Both, elastase-induced caspase activation and actin aggregate formation were inhibited by the allosteric modulation of β1 integrin. Under ATP depletion conditions, there is a net conversion of monomeric G-actin to polymeric F-actin resulting from an alteration in the ratio of ATP-G-actin and ADP-G-actin with the resultant F-actin forming dispersed aggregates. Actin polymerisation consumes 50% of total cellular ATP. We chose to characterise ATP dynamic changes in vitro following elastase induced-injury. We found not only the levels were reduced after prolonged exposure but preceding this reduction, abnormal fluctuations were detected at the onset of exposure to elastase. These responses were inhibited by allosteric modulation of β1 integrin. Recent report has indicated that the addition of ATP to lung epithelial cells inhibited injury (44).
Recent reports have shown that the administration of β4 thymosin, an actinsequestering protein, promoted cardiac repair after ischemia-reperfusion injury (22).
Additionally, gene disruption of caveolin-1, which is known to be involved in integrin clustering and activation, results in pulmonary fibrosis and impairment in liver regeneration after partial hepatectomy which was reversible by treatment with glucose integrin-mediated adhesion regulate cholesterol-rich membrane microdomain internalisation mediated by phospho-caveolin-1 (48) and caveolar endocytosis can be blocked by small interfering RNA knockdown of β1 integrin (49). Our findings that allosteric modulation inhibits elastase-induced caveolin phosphorylation reinforces the idea that, in injury, abnormal integrin activation, clustering and the resulting changes in the cytoskeleton could be key to cellular damage in emphysema.
In conclusion, we propose that elastase-induced progressive damage is partly due to anoikis resulting from an increase in cytoskeletal tension caused by increased actin polymerisation, rendering the cell rigid and susceptible to physiological forces.
More importantly, we have shown for the first time the potential therapeutic effect of allosteric modulation of β1 integrin in tissue repair in emphysema. We suggest a paradigm for the pathogenesis and treatment of emphysema based upon β1 integrin and its effect on cell survival, mediated by alteration of adhesion and cytoskeletal tethering and energy preservation. We propose that an initial insult changes the mechanical tethering of cells to ECM, perhaps due to ECM degradation (50) thus changing cell mechanosensing, leading to ATP depletion and eventual cell death. (yellow) and TTF-1 (red, Column II). Column III: An overlay of parenchyma and expression patterns of GATA-6 and TTF-1. Column IV: Detail of (Column I) at higher magnification. Column V: Detail of (Column II) at higher magnification. 
Methods.
Human lung explant culture and human lung cell isolation Human lung tissue specimens were obtained (and approved by NHS ethics committee and with consent) and cultured as either 20-30 mg explant strips or cells. Alveolar epithelial cells were isolated as described before (Elbert et. al., 1999 and Murphy et al., 1999) . The cells were then plated onto Transwells of 0.3um pore size (Sigma) and maintained in culture using 1:1 DMEM/F12:Small airway growth media (Cambrex BioScience Wokingham Ltd.) containing 1% fetal calf serum. The remaining tissue was treated with DMEM containing 40% fetal calf serum to inactivate the digestive enzymes and then washed using HEPES buffer. To isolate fibroblasts and smooth muscle cell populations, the tissue was then incubated in DMEM containing 1mg/ml collagenase, 0.5% trypsin and 200U/g DNAsI and maintained at 5% in an CO 2 incubator. The cell suspension was washed as above and cells seeded on multiwell culture plates and maintained in DMEM containing 10% fetal calf serum.
Cultures were subjected to serum starving overnight in a medium containing 0.1% fetal calf serum. Some collagenase digested plated cells were co-cultured with isolated alveolar epithelial cells Transwells at the time of commencing the starvation.
Functional modifying antibody against β1 integrin (Chemicon, clone JB1a, IgG1 ) was added to the cultures at a concentration of 1.44 and 0.48 μg/ml. The β1 integrin stimulatory antibody clone TS2/16 (IgG1) was also added at 0.9 μg/ml for 1 hour to demonstrate the specificity of the JB1a action. After antibody addition to the cells in culture, the medium was aspirated and the cell layer rinsed twice with ice-cold PBS.
The media was aspirated and preserved after the addition of protease inhibitors at -o C. In additional experiments, the effect of protein synthesis inhibition on β1 integrin mediated proteoglycan increase was tested by pretreating the human lung derived cells with 25μM cycloheximide. The effect of non-specific activation of metalloproteinases on β1 integrin mediated proteoglycan increase was tested by pretreating the human lung derived cells with 0.5M APMA (aminophenylmercuric acetate). To investigate the involvement of selected metalloproteinases in initiating the response observed with β1 integrin, specific neutralising antibodies for metalloproteinase-7 (1:1000, goat IgG, R&D systems) and metalloproteinase-9 (1:1000 of clone 6-6B, mouse IgG1, Oncogene
Research Products) were used. A broad spectrum inhibitor of metalloproteinases was also used at 2.3nM (metalloproteinase inhibitor III, Calbiochem).
SDS-PAGE was also used to separate the denatured proteoglycan and proteins from the tissue concentrated tissue culture supernatants. Perlecan antibody immunoreactive to non-degraded forms of perlecan was used (7B5, mouse IgG1, Zymed Laboratories).
metalloproteinase-1 (clone 41-1E5, IgG2a against amino acids 332-350 of human metalloproteinase-1), inactive metalloproteinase-9 (clone 7-11C, mouse IgG1) and TIMP1 (clone 7-6C1, mouse IgG1) antibodies were all from Oncogene Research Products.
PPE-induced air space enlargement model in mice.
Female C57/BL6 mice (6) (7) (8) weeks old) were instilled intra-tracheally with porcine pancreatic elastase as detailed before (11). All procedures were approved by the UK Home Office and the Institutional Ethics Committee. At day 14 or 21, mice were treated intra-tracheally with the antiintegrin antibody JB1a at 3mg/kg in sterile PBS. The dose chosen is equivalent to the dose of clinically used antibodies against α4β1 integrin (Miller DH, et al. 2003) .
Control group was instilled initially with PBS and at day 14 or 21 with PBS. For the group treated at day 14, the animals were terminated at day 21 as follows: The animals were anaesthetised using sodium pentobarbitone (45mg/kg), paralysed using pancuronium bromide (0.8mg/kg) and tracheostomised and ventilated using a small animal ventilator (Flexivent, SCIREQ, Montreal) Gordon and Sweet's Reticulin stain was performed as a method of visualising collagen distribution in both injured and vehicle-treated lung. Briefly, sections were oxidised with 0.5% potassium permanganate, bleached with 1% oxalic acid, and treated with 2.5% ammonium iron (III) sulphate and a 5% silver nitrate/1.5% sodium hydroxide solution prior to reduction with 10% unbuffered formaldehyde. Visualisation of reticulin fibres was accomplished via treatment with 0.1% sodium chloroaurate and 3% sodium thiosulphate solutions. Sections were counterstained with neutral red prior to mounting.
Image Processing and Stereological Analysis. Colour images of reticulin-stained sections were subjected to automated image processing methods developed in-house using Image Pro Plus (Media Cybernetics). Briefly, a greyscale image representing the green channel (which shows the highest differentiation from background) was obtained by splitting the RGB channels. Sobel edge detection operators, dilation-erosion and erosion-dilation algorithms were used to enhance the image and to remove 'salt and pepper' noise. An area of interest measuring 200μm x 200μm was overlaid over a digitally-captured image of a reticulin-stained section and only events completely inside the frame or intersecting the two inclusion edges of the frame's left and lower aspects (South-West) were included. Events intersecting the right and upper aspects (NorthEast) of the frame were excluded, as were blood vessels other than the capillaries of the alveolus. These stereological methods are similar to those described previously (Ochs et al., 2004) . 2D objects that were counted using this method included alveolar septal junctions, free septal ends, and contiguous airspaces. A total of 15 non-overlapping frames were included per section as this was sufficient to achieve a running mean. The mean number of events on sections obtained from vehicle-treated (n=5), PPE-treated alone or in combination with JB1a (2μg/ml) and ZVAD-fmk at 10 or 20 μM. At the end of the 6 hour period, the media was aspirated and caspase 3 activity assayed using Caspase-Glo TM 3/7 (Promega) according to the manufacturers' instructions. Separate experiments were performed at up to 6 hours of stretching where the cells were fixed with 4% paraformaldehyde and stained using Alexa-fluor phalloidin and TO-PRO3 (Molecular Probes). Images were aquired using Zeiss Axioskope using a x63 water achroplan objective and analysed using LSM 5 Image software.
In a separate set of experiments lung fibroblasts and epithelial cells were seeded onto 96 multi-well plates as described above. The cells were starved in media containing 0.1%
FCS then in DMEM-glucose-free with 0.1% FCS for 45 minutes before treating with (i) PPE at 0.3U/ml alone or (ii) PPE preceded by JB1a (2μg/ml). At the end of the experiment, ATP levels were measured using a bioluminescent ATP kit (Perkin Elmer).
Time-lapse studies. Cells were cultured as described in methods at 50,000 cell/membrane onto collagen I Bioflex membranes using silicone gaskets of 10mm diameter. Cells were starved with media contaning 0.1% FCS and Syto 16 (Molecular Probes). The media was removed and Alexa-Fluor 647 labelled G-actin from rabbit (100μg/membrane) was loaded using Influx (Molecular Probes). The cells were loaded with PhiPhiLux-G 2 D 2 for visualisation of caspase activation (OncoImmune). The membrane was then mounted onto the StageFlexer (FlexCell), placed on the stage of an upright Leica-TCS-NT confocal microscope system (Leica Microsystems GmbH, Germany) and subjected to 2-10% cyclic stretch at 1 Hz for up to 6 hours. Images were collected simultaneously from 3 channels at 1 minute intervals, using the x10 lens. The resulting timelapse movies were collated and analysed with Imaris software (Bitplane AG, Switzerland). At various time points during the study, the membrane was held static while serial optical sections were acquired. The three fluorescent channels supplemented by the collection of the brightfield channel image.
Three-dimensional confocal microspy. NCI-H441 cells and human lung fibroblasts were cultured as described above onto collagen I-coated glass coverslips at 20,000 cells within an area of 5mm in diameter. The media was removed and Alexa-Fluor 647 labelled G-actin (30μg/coverslip) from rabbit was loaded using Influx (Molecular Probes). The cells were loaded with PhiPhiLux-G 2 D 2 for visualisation of caspase activation (OncoImmune) and FL-ganglioside 1 (GM1, Molecular probes) to visualise the plasma membrane. Images were collected through 4 separate channels (GM1: λ = 488 ,caspase λ = 568, actin: λ = 647 and brightfield) using x63 water lens and Zeiss LSM510 CLSM microscope. The resulting images were analysed with Imaris software (Bitplane AG, Switzerland). Three-dimensional images were reconstructed.
Caveolin-1 extraction and analyses. NCI-H441 cells and human lung fibroblasts were cultured as described above. Media was changed prior to the experiment to 0.1% FCS containing media. Vehicle, PPE (0.3U/ml) or PPE in the presence of JB1a (2 μg/ml) containing media was added onto the cells for 2 hours. Cells were extracted using lysis buffer composed of 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM Na3VO4 containing 1% Triton X-100 and protease inhibitors (Roche) for 1 hour at 4 o C and sheared repeatedly using 22G needle on ice. Total protein was quantified using Bradford's assay method (BioRad). The extracts (1ml) were mixed with equal volume of 85% w/v sucrose in extraction buffer without Triton x-100 and layered with 2ml of 35% w/v sucrose in buffer and then 1 ml of 5% w/v sucrose in buffer. The gradients were prepared at 4 o C. The gradients were then centrifuged at 38,000 rpm for 16 hours at 4 o C. Fraction were collected from the top (0.4 ml fractions) and separated onto 13% SDS-PAGE and transferred onto nitrocellulose membranes then probed for β1 integrin using JB1a (Chemicon), caveolin-1 (BD Biosciences), phosphorylated caveolin-1 (Cell Biosciences) and talin (Sigma-Aldrich), and developed with HRP-conjugated secondary antibodies using the ECL-plus chemiluminescence system (Amersham Biosciences).
Supplementary
Figure. An image which highlights the peak activation of caspase (red) following elastase-induced injury in vitro, and its presence in high actin aggregatecontaining (blue) cell populations.
